Clincosm LogoSign in Get a demo

Cancer Control Following Polypectomy

Sponsor
Memorial Sloan Kettering Cancer Center (Other)
Overall Status
Completed
CT.gov ID
NCT00591279
Collaborator
National Cancer Institute (NCI) (NIH), Mount Sinai Hospital, New York (Other), Minneapolis Veterans Affairs Medical Center (U.S. Fed), Medical College of Wisconsin (Other), St. Lukes hospital in Racine, Wiscousin (Other), Massachusetts General Hospital (Other), Cedars-Sinai Medical Center (Other), Valley Presbyterian Hospital (Other)
110
Enrollment
1
Location
431
Actual Duration (Months)
0.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This study evaluates strategies for the surveillance of post-polypectomy patients for the control of bladder cancer

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    110 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Cancer Control Following Polypectomy
    Actual Study Start Date :
    Feb 1, 1981
    Actual Primary Completion Date :
    Jan 1, 2017
    Actual Study Completion Date :
    Jan 1, 2017

    Arms and Interventions

    Arm Intervention/Treatment
    A

    Barium enema and colonoscopy at one and three years after entry.
    B

    Barium enema and colonoscopy at three years only after entry.

    Outcome Measures

    Primary Outcome Measures

    1. evaluate strategies for the surveillance of post-polypectomy patients [6 years]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:

    • referral for colonoscopy or

    • referral for proctoscopy or for a complete colonoscopy after a proctoscopy or flexible sigmoidoscopy

    Exclusion Criteria:
    • prior history of colon cancer, unrelated polypectomy, inflammatory bowel disease, family history of familial polyposis

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Memorial Sloan Kettering Cancer Center New York New York United States 10065

    Sponsors and Collaborators

    • Memorial Sloan Kettering Cancer Center
    • National Cancer Institute (NCI)
    • Mount Sinai Hospital, New York
    • Minneapolis Veterans Affairs Medical Center
    • Medical College of Wisconsin
    • St. Lukes hospital in Racine, Wiscousin
    • Massachusetts General Hospital
    • Cedars-Sinai Medical Center
    • Valley Presbyterian Hospital

    Investigators

    • Principal Investigator: Sidney Winawer, MD, Memorial Sloan Kettering Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Memorial Sloan Kettering Cancer Center
    ClinicalTrials.gov Identifier:
    NCT00591279
    Other Study ID Numbers:
    • 81-035
    First Posted:
    Jan 11, 2008
    Last Update Posted:
    Feb 2, 2017
    Last Verified:
    Jan 1, 2017
    Keywords provided by Memorial Sloan Kettering Cancer Center
    large bowel cancer
    polyps
    colorectal cancer
    Additional relevant MeSH terms:
    Colonic Neoplasms

    Study Results

    No Results Posted as of Feb 2, 2017